Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human NRXN3 ELISA Kit (AC2545)
Cat.#: ASET-1134
Specifications
Description Human NRXN3 ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human NRXN3 concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 2.73 ng/L Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 75-1200 ng/L Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2209 Mouse TMPRSS2 ELISA Kit (AC3620) Quantitative inquiry ASET-1057 Human COMT ELISA Kit (AC2468) Quantitative inquiry ASET-1172 Human SLC24A1 ELISA Kit (AC2583) Quantitative inquiry ASET-1996 Human SCAMP1 ELISA Kit (AC3407) Quantitative inquiry ASET-1508 Mouse Aromatase ELISA Kit (AC2919) Quantitative inquiry ASET-1951 Mouse Midkine ELISA Kit (AC3362) Quantitative inquiry ASET-1414 Mouse beta 1 Adrenergic Receptor ELISA Kit (AC2825) Quantitative inquiry ASET-2199 Mouse Ghrelin ELISA Kit (AC3610) Quantitative inquiry ASET-1520 Rat Neuroligin 3 ELISA Kit (AC2931) Quantitative inquiry ASET-1587 Human VCAM1 ELISA Kit (AC2998) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
0Inquiry Basket